Inflammatory bowel disease - is there something new in the immunological background?

Folia Histochemica et Cytobiologica

Volumn 49, Issue 2, 2011, Pages 357-362

  Marszalek, Andrzej ^a,b   Marciniak, Ryszard ^a   Szkaradkiewicz, Andrzej ^a   Wasilewska, Agnieszka ^a   Chudzicka Strugala, Izabela ^a   Ziuziakowska, Hanna ^b   Zebrowska, Malgorzata ^b   Majewski, Przemyslaw ^a   Banasiewicz, Tomasz ^a   Drews, Michal ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

CMV; EBV; Histopathology; Inflammatory bowel disease

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIGEN; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IN SITU HYBRIDIZATION; MALE; POLYMERASE CHAIN REACTION; STEROID THERAPY; TUBERCULOSIS; ULCERATIVE COLITIS; ADOLESCENT; BIOLOGICAL MODEL; ENTERITIS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; VIROLOGY; VIRUS INFECTION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 4; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; STEROIDS; VIRUS DISEASES;

EID: 80055093390     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0049     Document Type: Article

References (22)

1. Geboes K. Indeterminate colitis: a review of concept - what's in a name? Inflamm Bowel Dis. 2008;14:850-857.
2. Dimitroulia E. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:879-884.
3. Kirsner JB. Inflammatory bowel disease: from the mystical to the cellular and now the molecular. World J Gastroenterol. 2005;26:4127-4128.
4. Bernstein CN. Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease. J Clin Microbiol. 2007;45:968-971.
5. Gophna U. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol. 2006;44:4136-4141.
6. Swidsinski A. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005;43:3380-3389.
7. Tlaskalova-Hogenova H. Commensal bacteria (normal microflora), mucosal intensity and chronic inflammatory and autoimmune disease. Immunol Lett. 2004;93:97-108.
8. Sepulveda S. Inflammatory bowel diseases: an immunological approach. Rev Med Chile. 2008;136:367-375.
9. Galiatsatos P. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci. 2005; 50:609-616.
10. Minami M. Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan. World J Gastroenterol. 2007; 13:754-760.
11. Kuwabara A. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2007;42:823-829.
12. Roskell DE. HIV associated cytomegalovirus colitis as a mimic of inflammatory bowel disease. Gut. 1995;37:148-150.
13. Takahashi Y. Prevalence of cytomegalovirus infection in inflammatory bowel disease patients. Dis Colon Rectum. 2004;47:722-726.
14. Jaber S. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest. 2005;127:233-241.
15. Kishore J. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53:1155-1160.
16. Inoue T. Refractory ulcerative colitis accompanied with cytomegalovirus colitis and multiple liver abscesses: a case report. World J Gastroenterol. 2005;33:5241-5244.
17. Olsen S. Cytomegalovirus infection in Crohn's colitis. J R Soc Med. 2004;97:335-336.
18. Criscuoli V. Cytomegalovirus and inflammatory bowel disease: is there a link? World J Gastroenterol. 2006; 30:4813-4818.
19. Spieker T. Distribution and phenotype of Epstein-Barr virusinfected cells in inflammatory bowel disease. Am J Pathol. 2000;157:51-57.
20. Anagnostopoulos I. Morphology, immunophenotype and distribution of latently and/or productively Epstein-Barr virus- -infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood. 1995;85:744-750.
21. Jaber S. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest. 2005;127:233-241.
22. Andoh A. Mucosal cytokine network in inflammatory bowel disease. World J Gastroenterol. 2008;33:5154-5161.